ALX Oncology Holdings - Stock Price History | ALXO

Historical daily share price chart and data for ALX Oncology Holdings since 2021 adjusted for splits. The latest closing stock price for ALX Oncology Holdings as of September 24, 2021 is 74.98.
  • The all-time high ALX Oncology Holdings stock closing price was 112.26 on December 10, 2020.
  • The ALX Oncology Holdings 52-week high stock price is 117.45, which is 56.6% above the current share price.
  • The ALX Oncology Holdings 52-week low stock price is 32.51, which is 56.6% below the current share price.
  • The average ALX Oncology Holdings stock price for the last 52 weeks is 65.75.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
ALX Oncology Holdings Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 50.7102 30.0000 112.2600 29.3600 86.2000 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $3.178B $0.001B
ALX Oncology Holdings a clinical-stage immuno-oncology company. It focuses on developing therapies for patients fighting cancer. The company's product candidate consist ALX148, which is in clinical stage. ALX Oncology Holdings based in Burlingame, California.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $134.727B 8.97
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.500B 21.17
Biohaven Pharmaceutical Holding (BHVN) United States $8.865B 0.00
Emergent Biosolutions (EBS) United States $2.891B 6.97
Arcus Biosciences (RCUS) United States $2.641B 0.00
Myovant Sciences (MYOV) United Kingdom $2.145B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.998B 0.00
Zymeworks (ZYME) Canada $1.380B 0.00
Ambrx Biopharma (AMAM) United States $0.521B 0.00
SQZ Biotechnologies (SQZ) United States $0.427B 0.00
Enzo Biochem (ENZ) United States $0.175B 51.71